Technoglitch
Core Member
Bangalore-based HealthCare Global Enterprises initial public offering (IPO) has opened for subscription Wednesday. The issue which will close on March 18, priced at Rs 205-218 per share is planning to raise Rs 611 crore to Rs 650 crore. This is fourth healthcare IPO from December and Dr Lals, Alkem and Narayana Healthcare have received overwhelming response at debut.
#1 The company operates largest private cancer care network with a pan-India presence, consisting of 18 cancer centres across India, including 14 comprehensive cancer centres, three freestanding diagnostic centres and a day care chemotherapy centre. In 2013, the company entered the fertility segment by acquiring 50.1 percent stake in BACC Healthcare, which operates four fertility centres under the Milann brand in Bangalore. HCG also operates two multi-speciality hospitals in Gujarat. #2 During H1FY16 and FY15, HCG registered 18,079 and 37,458 new cancerpatients across its network and delivered radiation therapy to 6,163 and 12,647 patients, respectively. It has also performed 12,253 and 23,988 PET-CT procedures, 25,453 and 48,360 chemotherapy administrations and 4,630 and 8,707 surgeries, respectively. Out of the 14 cancer centres under HCG’s network, only four are owned and controlled by HCG while others are on joint venture or profit sharing basis.
4 Hospital IPOs in 3 mnths: Appetite left for Healthcare Global? - Moneycontrol.com
#1 The company operates largest private cancer care network with a pan-India presence, consisting of 18 cancer centres across India, including 14 comprehensive cancer centres, three freestanding diagnostic centres and a day care chemotherapy centre. In 2013, the company entered the fertility segment by acquiring 50.1 percent stake in BACC Healthcare, which operates four fertility centres under the Milann brand in Bangalore. HCG also operates two multi-speciality hospitals in Gujarat. #2 During H1FY16 and FY15, HCG registered 18,079 and 37,458 new cancerpatients across its network and delivered radiation therapy to 6,163 and 12,647 patients, respectively. It has also performed 12,253 and 23,988 PET-CT procedures, 25,453 and 48,360 chemotherapy administrations and 4,630 and 8,707 surgeries, respectively. Out of the 14 cancer centres under HCG’s network, only four are owned and controlled by HCG while others are on joint venture or profit sharing basis.
4 Hospital IPOs in 3 mnths: Appetite left for Healthcare Global? - Moneycontrol.com
